WASHINGTON — President Trump on Monday signed
an executive order directing federal agencies to cut two regulations
for every new one that they adopt, a move that could have significant
implications for the Food and Drug Administration.
In
addition, agencies cannot propose any new regulation that isn’t currently
listed in the Unified Regulatory Agenda without prior White House approval.
The “one
in, two out” policy also appears to apply to agency guidance documents. The
recently passed 21st Century Cures Act alone requires the agency to produce at
least 10 guidance documents.
Trump,
who vowed throughout his campaign to ease the burden of government regulations
in order to promote innovation, pledged at the signing ceremony that the
order would be “the biggest such act our country has ever seen.”
“There will be regulation, there will be control, but it will be
normalized control,” he said.
GMP News, GMP guidelines, GMP Violations, GMP warnings, GMP Trends. A Public Health Global News Portal. (This story has not been edited by GMP Violations staff and is auto-generated from a syndicated feed.) Disclaimer: The Logos/Images & content posted here are belongs to respective to Authority / owners of firm. The Article posted under public health importance news.
Posts
0 comments:
Post a Comment